Management

CH_metabiota_wolfe_nathan_1000

Nathan studied at Stanford and received his doctorate in Immunology and Infectious Disease from Harvard in 1998. Prior to founding Metabiota in 2008 he served as an Assistant Professor at Johns Hopkins and a Full Professor at UCLA.

Nathan was awarded the National Institute of Health Director’s Pioneer Award in 2005. In 2009 he was chosen as a National Geographic Emerging Explorer and in 2010 he was elected a Young Global Leader by the World Economic Forum. He was named one of Time Magazine’s 100 Most Influential People in 2011.

Nathan has published over 100 articles and chapters. His work has been published in or covered by Nature, Science, PNAS, JAMA, The New York Times, The New Yorker, The Economist, The WSJ, Wired, NPR, and Forbes among others. His first book, The Viral Storm has been published in six languages and was shortlisted for the Royal Society’s Winton Prize.

Nathan Wolfe

FOUNDER AND CHAIRMAN
CH_metabiota_rossi_bill_1000

Bill was formerly the COO of Bidgely, a Khosla funded energy software company selling to electric utilities worldwide. Prior to that, Bill was the CMO at Enphase Energy where he led the product and marketing organization and helped take the company public in March, 2012. Before Enphase, he ran marketing for Google Apps establishing Google as the leader in web-based collaboration. Bill started his career at Cisco Systems where he eventually ran the company's Enterprise wireless business as VP/GM. He graduated from Dartmouth College with a BS in Electrical Engineering. Bill also holds an MBA from the Harvard Business School.

Bill Rossi

CEO
CH_metabiota_rubin_eddy_1000

Eddy Rubin joined Metabiota as Chief Science Officer in July 2016 after several decades of running large-scale science programs at the Lawrence Berkeley National Laboratory.

Just prior to joining Metabiota, Dr. Rubin acted as the Director of the DOE Joint Genome Institute (JGI). The JGI is a large genomic facility and was a major participant in the Human Genome Project under his leadership, sequencing 13% of the human genome as well as the genomes of thousands of microbes, viruses and fungi. His research has included a series of pioneering studies in the area of metagenomics, deriving important insights from his investigation of the microbial communities inhabiting a variety of environments. Dr. Rubin has published over 250 peer-reviewed manuscripts with more than 35 of them appearing in the journals Science and Nature. He is a member of the Genome Canada Board of Directors, Chair of the Genomic Institute of Singapore’s Scientific Advisory Board and was a member of the Welcome Trust Sanger Center’s Scientific Advisory Board from 2008-2012. He received an Honorary Doctorate of Science degree from Middlebury College, the University of Rochester Dean’s Award, the Netherlands Heart Association Declaration of Esteem, the American Heart Association Established Investigator Award, and has been inducted into the American Society of Clinical Investigation. He served as a member of the Board of Reviewing Editors for the journal Science from 2001 to 2012.

Dr. Rubin received a BA in Physics at the University of California San Diego, his MD & PhD (Biophysics) at the University of Rochester, and completed his clinical training in Human Genetics at the University of California San Francisco.

Eddy Rubin MD, PhD

CSO
CH_metabiota_hlaing_htin_206_w3_RGB 1

Htin Hlaing is the Vice President of Engineering at Metabiota with extensive experience in R&D engineering and software integration. In this role, Htin builds and heads world class engineering team delivering Metabiota's product offerings to the global customer base. Htin's a hands-on executive with expertise in agile development, big data infrastructure, internet technologies, cloud services, enterprise software and product design.

Prior to Metabiota, Htin was Vice President of Engineering at SugarSync, a Cloud backup and sync company (acquired by j2 Global). At SugarSync, Htin was responsible for transforming the distributed engineering teams to be highly productive agile teams delivering all of SugarSync's desktop, mobile, web based products and massively distributed backend infrastructure. Prior to SugarSync, Htin held senior management positions at Flurry, Inc (acquired by Yahoo! Inc.) and Attributor Corporation (acquired by Digimarc). Before coming to Attributor, he held engineering management positions in various Silicon Valley startup companies.

He holds Bachelors of Science degree in Computer Science from University of California, Irvine and Masters of Science degree in Software Management from Carnegie Mellon University.

Htin Hlaing

VICE PRESIDENT OF ENGINEERING
CH_metabiota_dixon_marissa_1000

Marissa Dixon has broad Human Resources experience in a range of high-growth, fast-paced industries. Over the last several years, she has specialized in the distinctive needs of the Biotechnology field.

Prior to joining Metabiota, Marissa served as the Director of Human Resources for DuPont Industrial Biosciences supporting the Research & Development team in 4 countries. Marissa has a proven track record of engaging global teams to execute on company initiatives in unique and culturally significant ways.

Marissa holds an M.S. in Human Resource Design and an M.A. in Psychology from Claremont Graduate University as well as an undergraduate degree in Social Sciences from Cal Poly San Luis Obispo.

Marissa Dixon

VICE PRESIDENT OF HUMAN RESOURCES
CH_metabiota_bruursema_jen_800

Throughout her career, Jen Bruursema has commercialized and marketed novel approaches to preventing and diagnosing infectious diseases as well as detecting and treating life-threatening genetic conditions.

From her first foray into molecular diagnostics at Digene Corporation, later acquired by QIAGEN, she exponentially grew clinical demand for the Digene HPV Test brand that spurred a global multi-billion dollar industry for human papillomavirus DNA testing.

She also designed marketing strategy and tactics to position assays for CMV, EBV, West Nile and other infectious agents to the CLIA laboratory customer segment. She further expanded her product portfolio to include next generation sequencing for the detection of Down syndrome as Director of Marketing at Roche-Ariosa Diagnostics, stem cell therapeutics for regenerative medicine applications as Senior Director of Global Healthcare Communications at AMAG Pharmaceuticals; and next generation sequencing for bacterial, fungal and viral detection as Head of Marketing at Karius.

Jen has underpinned this career expertise working across a broad spectrum of financial and cultural environments, including startups, private equity-backed companies and publicly traded corporations.

Jen Bruursema

HEAD OF CORPORATE MARKETING
CH_metabiota_hodge_megan_1000

Megan Hodge is Metabiota’s Global Head of Business Development, Risk Products. She was previously the Global Managing Director and Branch Manager of Guy Carpenter’s Chicago USA office. In this past role, she closely worked with a number of nationwide and global P&C insurance providers to analyze their business portfolios and understand their strategic objectives, including: optimizing reinsurance solutions (i.e. designing programs that best meet each company’s unique risk and capital management needs) as well as to address their broader needs (i.e. outside of reinsurance, ranging from growth initiatives to product development to incorporating emerging technologies into their current platforms).

Prior to joining Guy Carpenter in 2009, Megan was part of Aon Benfield’s (fka Benfield’s) North American reinsurance intermediary practice. She began her career at Arthur Andersen in its value-based solutions consulting practice, with a focus on insurance recoveries.

Additionally, Megan is an outgoing Board Member and Grants Committee member of Midwest Division - Insurance Industry Charitable Foundation (IICF), a Major Grants Committee member of the Oak Park River Forest Infant Welfare Society, and a member of the Leukemia & Lymphoma Society’s Chicago-based “Just Cure It” team.

Megan Stewart Hodge

GLOBAL HEAD OF BUSINESS DEVELOPMENT, RISK PRODUCTS